NBTX Stock Analysis: Buy, Sell, or Hold?
NBTX - Nanobiotix S.A. American Depositary Shares
$43.55
-0.13 (-0.30%)
▼
5d:
+13.68%
30d:
+10.11%
90d:
+8.39%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Sep 29, 2026
Get Alerted When NBTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: NBTX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: NBTX shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: NBTX is currently trading at $43.55, which is considered extended relative to its 30-day fair value range of $37.34 to $41.60. From a valuation perspective, the stock is trading at a discount (Forward PE: -148.5) compared to its historical average (178.3). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, NBTX is in a uptrend. Immediate support is located at $35.41, while resistance sits at $45.74.
Market Sentiment: NBTX scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NBTX is in a uptrend. Immediate support is located at $35.41, while resistance sits at $45.74.
Market Sentiment: NBTX scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$37.34 -
$41.60
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
28.6%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (23/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($45.61)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$37.34 -
$41.60
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$35.41
Resistance Level
$45.74
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-148.53
Wall Street Target
$45.61
(+4.7%)
Revenue Growth (YoY)
186.8%
Profit Margin
-73.5%
PE vs Historical
-148.5 vs 178.3
CHEAP
Share & Embed Analysis
Last updated: August 23, 2026 7:04 AM ET
Data refreshes hourly during market hours. Next update: 8:04 AM
Data refreshes hourly during market hours. Next update: 8:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NBTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$109 | 66 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 41 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 27 SELL |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 41 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$23 | 49 HOLD |
